Literature DB >> 31499188

Advances in differentiation therapy for osteosarcoma.

Yingqian Chen1, Ji Cao1, Ning Zhang2, Bo Yang1, Qiaojun He1, Xuejing Shao3, Meidan Ying4.   

Abstract

Differentiation therapy involves the use of agents that can induce differentiation in cancer cells, with the irreversible loss of tumour phenotype. The application of differentiation therapy in osteosarcoma has made progress because of a better understanding of the potential links between differentiation defects and tumorigenesis. Here, we review recent studies on differentiation therapy for osteosarcoma, describing a variety of differentiation inducers. By highlighting these examples of drug-induced osteosarcoma cell differentiation, we can acquire unique insights into not only osteosarcoma treatment, but also novel approaches to transform differentiating drugs into more effective therapies for other solid tumours.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31499188     DOI: 10.1016/j.drudis.2019.08.010

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  11 in total

1.  Dihydrotanshinone I Enhances Cell Adhesion and Inhibits Cell Migration in Osteosarcoma U-2 OS Cells through CD44 and Chemokine Signaling.

Authors:  Lanyan Fan; Chen Peng; Xiaoping Zhu; Yawen Liang; Tianyi Xu; Peng Xu; Shihua Wu
Journal:  Molecules       Date:  2022-06-09       Impact factor: 4.927

2.  Stearoyl-CoA Desaturase-1 Attenuates the High Shear Force Damage Effect on Human MG63 Osteosarcoma Cells.

Authors:  Kuo-Chin Huang; Po-Yao Chuang; Rong-Ze Hsieh; Cheng-Nan Chen; Shun-Fu Chang; Yu-Ping Su
Journal:  Int J Mol Sci       Date:  2020-07-02       Impact factor: 5.923

3.  Effects of Inonotus obliquus Polysaccharides on Proliferation, Invasion, Migration, and Apoptosis of Osteosarcoma Cells.

Authors:  Baohui Su; Xuezhi Yan; Yuezhong Li; Junshan Zhang; Xiaoyan Xia
Journal:  Anal Cell Pathol (Amst)       Date:  2020-11-17       Impact factor: 2.916

Review 4.  Mechanisms of Resistance to Conventional Therapies for Osteosarcoma.

Authors:  Louise Marchandet; Morgane Lallier; Céline Charrier; Marc Baud'huin; Benjamin Ory; François Lamoureux
Journal:  Cancers (Basel)       Date:  2021-02-08       Impact factor: 6.639

5.  The biological function and clinical significance of STIL in osteosarcoma.

Authors:  Shu-Fan Ji; Sheng-Lian Wen; Yu Sun; Pi-Wei Huang; Hao Wu; Mao-Lin He
Journal:  Cancer Cell Int       Date:  2021-04-15       Impact factor: 5.722

6.  Alantolactone inhibits proliferation, metastasis and promotes apoptosis of human osteosarcoma cells by suppressing Wnt/β-catenin and MAPKs signaling pathways.

Authors:  Chunmei Yang; Lulu Zhang; Huakun Huang; Xiaohui Yuan; Ping Zhang; Caihong Ye; Mengqi Wei; Yanran Huang; Xiaoji Luo; Jinyong Luo
Journal:  Genes Dis       Date:  2020-08-08

7.  Comprehensive Analysis of a Zinc Finger Protein Gene-Based Signature with Regard to Prognosis and Tumor Immune Microenvironment in Osteosarcoma.

Authors:  Xiangran Sun; Di Zheng; Weichun Guo
Journal:  Front Genet       Date:  2022-02-25       Impact factor: 4.599

8.  miR-148b-3p, as a tumor suppressor, targets son of sevenless homolog 1 to regulate the malignant progression in human osteosarcoma.

Authors:  Guodong Liu; Honggang Mao; Yan Liu; Zun Zhang; Si Ha; Xiaoyan Zhang
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

9.  Analysis of Intracellular Magnesium and Mineral Depositions during Osteogenic Commitment of 3D Cultured Saos2 Cells.

Authors:  Giovanna Picone; Concettina Cappadone; Alice Pasini; Joseph Lovecchio; Marilisa Cortesi; Giovanna Farruggia; Marco Lombardo; Alessandra Gianoncelli; Lucia Mancini; Menk Ralf H; Sandro Donato; Emanuele Giordano; Emil Malucelli; Stefano Iotti
Journal:  Int J Mol Sci       Date:  2020-03-30       Impact factor: 5.923

10.  Multiple Effects of Resveratrol on Osteosarcoma Cell Lines.

Authors:  Angela De Luca; Daniele Bellavia; Lavinia Raimondi; Valeria Carina; Viviana Costa; Milena Fini; Gianluca Giavaresi
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.